Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
223 studies found for:    glioblastoma | Recruiting | Interventional Studies
Show Display Options
Rank Status Study
1 Recruiting Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
Condition: Glioblastoma Multiforme
Interventions: Dietary Supplement: Ketogenic diet;   Dietary Supplement: Standard diet
2 Recruiting Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: F-MISO;   Other: Cerebral magnetic resonance imagery;   Drug: Bevacizumab;   Other: Clinical examination
3 Recruiting Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Condition: Glioblastoma Multiforme
Intervention: Other: ketogenic diet
4 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
5 Recruiting Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients
Condition: Glioblastoma Multiforme
Intervention: Drug: PQR309
6 Recruiting Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma;   Recurrent Glioblastoma;   Brain Tumor
Intervention: Drug: Tesevatinib
7 Recruiting Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
Condition: Glioblastoma
Intervention: Biological: Personalized cellular vaccine
8 Recruiting Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
Condition: Adult Glioblastoma
Interventions: Radiation: Radiation;   Device: 3 Tesla magnetic resonance imaging;   Device: Chemical exchange saturation transfer MRI;   Device: Diffusion weighted MRI;   Device: Dynamic contrast enhancement MRI;   Device: Dynamic susceptibility contrast MRI
9 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
10 Recruiting Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
11 Recruiting Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: anti-EGFRvIII CAR T cells;   Drug: cyclophosphamide;   Drug: Fludarabine
12 Recruiting Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Biological: ALECSAT;   Radiation: radiotherapy;   Drug: Temozolomide
13 Recruiting Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: G-202
14 Recruiting Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: SRT to the resection cavity
15 Recruiting Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Temozolomide;   Biological: T Cell Infusion;   Procedure: Surgery;   Behavioral: Phone Calls
16 Recruiting A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Condition: Glioblastoma
Interventions: Drug: BBI608;   Drug: Temozolomide
17 Recruiting Trial of Hypofractionated Radiation Therapy for Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Hypofractionated radiation therapy;   Radiation: Standard radiation therapy
18 Recruiting Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model
Condition: Glioblastoma
Intervention: Device: 7 Tesla MRI, no contrast agent
19 Recruiting Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Procedure: Standard surgery (neuronavigation-guided);   Radiation: Intraoperative radiotherapy;   Radiation: Radiochemotherapy;   Drug: Temozolomide
20 Recruiting Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
Condition: Glioblastoma
Interventions: Device: iMRI-guided surgery;   Drug: 5-ALA-guided surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.